Journal
ELIFE
Volume 9, Issue -, Pages -Publisher
ELIFE SCIENCES PUBLICATIONS LTD
DOI: 10.7554/eLife.62199
Keywords
-
Categories
Funding
- National Institute on Aging [RF1AG057181, R37AG027924, R01AG046205, RF1AG051504, P01NS074969, P30AG062677, R21AG052423]
- Cure Alzheimer's Fund
- Japan Heart Foundation
- Naito Foundation
- BrightFocus Foundation
- National Center for Geriatrics and Gerontology
- Hori Sciences and Arts Foundation
- NACC Junior Investigator Award
Ask authors/readers for more resources
Although the epsilon 2 allele of apolipoprotein E (APOE2) benefits longevity, its mechanism is not understood. The protective effects of the APOE2 on Alzheimer's disease (AD) risk, particularly through their effects on amyloid or tau accumulation, may confound APOE2 effects on longevity. Herein, we showed that the association between APOE2 and longer lifespan persisted irrespective of AD status, including its neuropathology, by analyzing clinical datasets as well as animal models. Notably, APOE2 was associated with preserved activity during aging, which also associated with lifespan. In animal models, distinct apoE isoform levels, where APOE2 has the highest, were correlated with activity levels, while some forms of cholesterol and triglycerides were associated with apoE and activity levels. These results indicate that APOE2 can contribute to longevity independent of AD. Preserved activity would be an early-observable feature of APOE2-mediated longevity, where higher levels of apoE2 and its-associated lipid metabolism might be involved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available